LEPROT and gastric cancer: DeLong’s tests showed that the efficiency of MYOF was significantly better than that of CLIP1 (P < 0.001) and LEPROT (P = 0.037), and a heatmap showed distinct differences in gene expression profiles between gastric cancer and normal gastric tissue (Figure 1G).